News Chart Bukwang Pharmaceutical Co., Ltd.

Equities

A003000

KR7003000007

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
5,660 ^KRW	-1.05%		-2.58%	-7.21%

05-14	Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	CI

a38c07fa3deaf35b4496.k2mGYdNXOZDWDZGcjSNa2fMxApalgyUiUoQmjlMpZUI.3wLjWbwWVcHmXdPaukocm6xJRKKd-ghMF_1HxwpNOhrbIcsnsDpI57gg9g~be2e62b4249938b1c61230bdeaf23acb